Our study confirmed that FGFR1 protein overexpression is more frequent (6–9%) [19,43] than overexpression of FGFR2 and FGFR3 (3.4% and 6.6% [44]) in Sq-NSCLC. The gene discussed is FGFR2; the disease is non-small cell lung carcinoma.